13th April 2022 Underestimated newcomers: mid-cap biotech companies Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte The steadily growing importance of small and mid-cap biotech companies with innovative product pipelines has not yet been fully acknowledged by financial markets. 13th April 2022
